ModelEdge

Ikena Oncology Inc.

Filing Type	8-K
Filing Date	7/28/2025
Updated	7/29/25, 4:04 AM

Filing

Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Change in Shell Company Status, Reg. FD

EX-10.10EX-10.10

EX-10.14EX-10.14

EX-10.18EX-10.18

EX-10.20EX-10.20

EX-10.21EX-10.21

EX-10.22EX-10.22

EX-10.23EX-10.23

EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Change in Shell Company Status, Reg. FD

EX-99.2Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Change in Shell Company Status, Reg. FD